Cas no 163439-82-5 ((3R,4R)-1-Benzylpyrrolidine-3,4-diol)
(3R,4R)-1-Benzylpyrrolidine-3,4-diol Chemical and Physical Properties
Names and Identifiers
-
- (3R,4R)-1-Benzylpyrrolidine-3,4-diol
- (3R,4R)-(?)-1-Benzyl-3,4-pyrrolidinediol
- (3R,4R)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL
- (3R,4R)-(-)-1-Benzyl-3,4-pyrrolidinediol
- (3R,4R)-1-BENZYL-PYRROLIDINE-3,4-DIOL
- (3R,4R)-1-benzyl-3,4-dihydroxy-pyrrolidine
- (3R,4R)-1-(phenylMethyl)-3,4-Pyrrolidinediol
- (3R,4R)-(-)-1-Benzyl-3,4-pyrrolidindiol,97%
- (3R,4R)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL 97%
- (3R,4R)-1-(Phenylmethyl)-3,4-pyrrolidinediol,99%e.e.
- 76784-33-3
- FS-2183
- J-800407
- SCHEMBL71063
- (3R,4R)-(-)-1-Benzyl-3,4-pyrrolidinediol, >=97.0% (sum of enantiomers, HPLC)
- J-501253
- DTXSID20427376
- MFCD01073894
- AMY37472
- QJRIUWQPJVPYSO-GHMZBOCLSA-N
- trans-3,4-dihydroxy-N-benzylpyrrolidine
- AKOS005264658
- CHEMBL2335509
- AC-22436
- 163439-82-5
- CS-W015769
- rel-(3R,4R)-1-Benzylpyrrolidine-3,4-diol
- AKOS015994967
- 330152-66-4
- BP-12366
- 3,4-Pyrrolidinediol, 1-(phenylmethyl)-, (3R,4R)-
- DB-031899
-
- MDL: MFCD01073894
- Inchi: 1S/C11H15NO2/c13-10-7-12(8-11(10)14)6-9-4-2-1-3-5-9/h1-5,10-11,13-14H,6-8H2/t10-,11-/m1/s1
- InChI Key: QJRIUWQPJVPYSO-GHMZBOCLSA-N
- SMILES: O[C@@H]1CN(CC2C=CC=CC=2)C[C@H]1O
Computed Properties
- Exact Mass: 193.11000
- Monoisotopic Mass: 193.11
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 14
- Rotatable Bond Count: 2
- Complexity: 170
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 2
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 0.3
- Topological Polar Surface Area: 43.7A^2
Experimental Properties
- Color/Form: White to Yellow Solid
- Density: 1.0945 (rough estimate)
- Melting Point: 95-101 oC
- Boiling Point: 356.2°C at 760 mmHg
- Flash Point: 195.1 °C
- Refractive Index: 1.5041 (estimate)
- PSA: 43.70000
- LogP: 0.16190
- Sensitiveness: Sensitive to CO2
- Solubility: Not available
- Optical Activity: [α]20/D ?33.6±3°, c =?1.05% in methanol
(3R,4R)-1-Benzylpyrrolidine-3,4-diol Security Information
-
Symbol:
- Signal Word:Warning
- Hazard Statement: H315,H319,H335
- Warning Statement: P261,P305+P351+P338
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- Hazard Category Code: 36/37/38
- Safety Instruction: S26-S37/39
- FLUKA BRAND F CODES:10-34
-
Hazardous Material Identification:
- Storage Condition:Inert atmosphere,Room Temperature
- Risk Phrases:R36/37/38
- Safety Term:S26;S37/39
(3R,4R)-1-Benzylpyrrolidine-3,4-diol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A109000105-250mg |
(3R,4R)-1-benzylpyrrolidine-3,4-diol |
163439-82-5 | 98% | 250mg |
$680.00 | 2022-04-02 | |
| Alichem | A109000105-500mg |
(3R,4R)-1-benzylpyrrolidine-3,4-diol |
163439-82-5 | 98% | 500mg |
$980.00 | 2022-04-02 | |
| Alichem | A109000105-1g |
(3R,4R)-1-benzylpyrrolidine-3,4-diol |
163439-82-5 | 98% | 1g |
$1,685.00 | 2022-04-02 | |
| Fluorochem | 037126-1g |
3R,4R)-(-)-1-Benzyl-3,4-pyrrolidinediol |
163439-82-5 | 97% | 1g |
£44.00 | 2022-02-28 | |
| Fluorochem | 037126-5g |
3R,4R)-(-)-1-Benzyl-3,4-pyrrolidinediol |
163439-82-5 | 97% | 5g |
£127.00 | 2022-02-28 | |
| Fluorochem | 037126-10g |
3R,4R)-(-)-1-Benzyl-3,4-pyrrolidinediol |
163439-82-5 | 97% | 10g |
£216.00 | 2022-02-28 | |
| Fluorochem | 037126-25g |
3R,4R)-(-)-1-Benzyl-3,4-pyrrolidinediol |
163439-82-5 | 97% | 25g |
£531.00 | 2022-02-28 | |
| AstaTech | 54073-1/G |
(3R,4R)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL |
163439-82-5 | 97% | 1g |
$80 | 2023-09-17 | |
| AstaTech | 54073-5/G |
(3R,4R)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL |
163439-82-5 | 97% | 5g |
$248 | 2023-09-17 | |
| AstaTech | 54073-25/G |
(3R,4R)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL |
163439-82-5 | 97% | 25g |
$720 | 2023-09-17 |
(3R,4R)-1-Benzylpyrrolidine-3,4-diol Suppliers
(3R,4R)-1-Benzylpyrrolidine-3,4-diol Related Literature
-
Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
-
Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
-
Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
Additional information on (3R,4R)-1-Benzylpyrrolidine-3,4-diol
(3R,4R)-1-Benzylpyrrolidine-3,4-diol: A Comprehensive Overview
Introduction to (3R,4R)-1-Benzylpyrrolidine-3,4-diol
Cas No. 163439-82-5 is the Chemical Abstracts Service registry number for the compound (3R,4R)-1-Benzylpyrrolidine-3,4-diol, a structurally unique and bioactive molecule that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound is characterized by its pyrrolidine ring system, which is substituted with a benzyl group at position 1 and hydroxyl groups at positions 3 and 4 in an (R,R)-configuration. The stereochemistry of this molecule plays a crucial role in its biological activity and functional properties.
Recent advancements in synthetic methodologies have enabled the efficient synthesis of (3R,4R)-1-Benzylpyrrolidine-3,4-diol, making it accessible for various applications in drug discovery and chemical research. Its versatile structure allows for modifications that can enhance its bioavailability, selectivity, and therapeutic potential.
Chemical Structure and Synthesis
The core structure of (3R,4R)-1-Benzylpyrrolidine-3,4-diol consists of a five-membered pyrrolidine ring with a benzyl substituent at position 1. The hydroxyl groups at positions 3 and 4 are critical for its interactions with biological systems. The synthesis of this compound typically involves multi-step processes that include ring formation, substitution reactions, and stereochemical control to achieve the desired (R,R)-configuration.
Recent studies have explored novel synthetic pathways that utilize asymmetric catalysis to improve the enantiomeric excess of the product. These methods not only enhance the efficiency of synthesis but also reduce environmental impact by minimizing waste generation.
Biological Activity and Applications
(3R,4R)-1-Benzylpyrrolidine-3,4-diol has demonstrated promising biological activity in various assays. It exhibits potent antioxidant properties due to the hydroxyl groups' ability to scavenge free radicals. Additionally, it has shown potential as a lead compound in anti-inflammatory drug development due to its ability to inhibit pro-inflammatory cytokines.
In recent research, this compound has been investigated for its neuroprotective effects. Studies suggest that it may play a role in mitigating oxidative stress and reducing neuronal damage in models of neurodegenerative diseases such as Alzheimer's disease.
Pharmacokinetic Properties and Toxicology
The pharmacokinetic profile of (3R,4R)-1-Benzylpyrrolidine-3,4-diol is an essential consideration for its therapeutic applications. Preclinical studies indicate moderate absorption rates following oral administration, with significant distribution into tissues rich in oxidative stress markers. The compound exhibits a relatively long half-life, suggesting potential for sustained-release formulations.
Toxicological evaluations have revealed low acute toxicity profiles at therapeutic doses. Long-term toxicity studies are currently underway to assess its safety profile for chronic use.
Future Prospects and Research Directions
The future of (3R,4R)-1-Benzylpyrrolidine-3,4-diol lies in its potential as a platform molecule for drug development. Researchers are exploring its ability to serve as a scaffold for designing more potent and selective derivatives targeting specific diseases.
Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of this compound into clinical trials. Its unique combination of structural features and biological activities positions it as a promising candidate in the pipeline for novel therapeutics.
163439-82-5 ((3R,4R)-1-Benzylpyrrolidine-3,4-diol) Related Products
- 101930-07-8((R)-(+)-1-Benzyl-3-pyrrolidinol)
- 651734-92-8(2,3-Butanediol, 1-[(phenylmethyl)amino]-, (2R,3R)-)
- 90365-74-5((3S,4S)-1-Benzylpyrrolidine-3,4-diol)
- 101385-90-4((S)-1-Benzylpyrrolidin-3-ol)
- 247190-83-6(2,3-Butanediol, 1,4-bis[bis(phenylmethyl)amino]-, (2S,3S)-)
- 260389-82-0(1-benzylpyrrolidine-3,4-diol)
- 775-15-5(1-benzylpyrrolidin-3-ol)
- 122536-93-0(3-Pyrrolidinol,1-(phenylmethyl)-, hydrochloride (1:1), (3R)-)
- 76783-60-3(Cis-1-Benzyl-3,4-pyrrolidindiol Hydrochloride)
- 76784-33-3(cis-1-Benzylpyrrolidine-3,4-diol)